Latest News-Telix Pharmaceuticals Corporate Limited Mediaroom_Page

Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-10-27 10:23 3810

Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-10-27 06:44 3402

Telix Reports Third Quarter 2022 Financial Results

MELBOURNE, Australia, Oct. 20, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-10-20 06:09 2275

TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM

* OPALESCENCE Phase II feasibility study of TLX250-CDx in patients with triple-negative breast ca...

2022-10-18 06:43 2065

Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

* New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare's immuno...

2022-10-17 13:00 2672

Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging

MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-10-17 07:25 2109

Health Canada Approves Illuccix® for Prostate Cancer Imaging

MELBOURNE, Australia, Oct. 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-10-14 08:21 2306

First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent

MELBOURNE, Australia, Sept. 30, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix...

2022-09-30 02:30 3122

Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate

MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix...

2022-09-28 06:50 2118

First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent

MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix...

2022-09-28 05:00 2746

First Patient Enrolled in ProstACT TARGET Study

MELBOURNE, Australia, Sept. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix...

2022-09-27 05:00 2552

Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data

MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix...

2022-09-21 07:51 1863

Targeted Alpha Therapy Candidate: Bladder Cancer Study Completes Enrolment

MELBOURNE, Australia and NANTES, France, Aug. 24, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limite...

2022-08-24 05:56 4150

Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant

MELBOURNE, Australia, Aug. 8, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, ...

2022-08-08 07:55 3312

Telix APAC Report: Regulatory Progress for Prostate and Kidney Cancer Imaging

MELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, ...

2022-08-02 06:54 2783

BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging

Telix and BAMF Health use Illuccix® (kit for the preparation of Gallium Ga 68 gozetotide injection)...

2022-07-27 20:30 2872

Telix Reports Second Quarter 2022 Financial Results

MELBOURNE, Australia, July 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-07-21 08:34 3135

ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

MELBOURNE, Australia, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-07-11 08:26 2929

Kevin Richardson appointed as CEO, Telix Americas

MELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, ...

2022-07-11 08:13 3203

Telix and Invicro Advance AI Partnership

MELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

2022-06-14 19:00 2604